Clinical Trials Browser

Phase 3 × Completed × Carcinoma, Intraductal, Noninfiltrating × Clear all

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00769379 2025-06-12

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

Phase 3 Completed

2,014 enrolled 16 charts

Breast

Carcinoma, Intraductal, Noninfiltrating

NCT00072462 2024-09-19

IBIS-II DCIS

Phase 3 Completed

2,980 enrolled 14 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00003857 2022-05-25

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Phase 3 Completed

636 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02961790 2020-01-18

Oxybutynin Chloride in Managing Hot Flashes

Phase 3 Completed

150 enrolled 16 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Hot Flashes

NCT00053898 2018-09-20

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Phase 3 Completed

3,104 enrolled 16 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00438659 2016-08-01

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Phase 3 Completed

176 enrolled 10 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Radiation Injuries, Breast Neoplasms, Male

NCT01112254 2016-01-26

IRCIS

Phase 3 Completed

360 enrolled

Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00262899 2013-01-07

Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions

Phase 3 Completed

331 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Phase 3 Completed

313 enrolled

BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Clinical Trials

Intraoperative Gamma Camera for Breast Cancer Surgery

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

IBIS-II DCIS

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Oxybutynin Chloride in Managing Hot Flashes

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

IRCIS

Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions

S9630, Medroxyprogesterone in Treating Women With Breast Cancer